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Soluble glucose dehydrogenase (s-GDH) from the bacterium Acin-
etobacter calcoaceticus is a classical quinoprotein. It requires the
cofactor pyrroloquinoline quinone (PQQ) to catalyze the oxidation
of glucose to gluconolactone. The precise catalytic role of PQQ in
s-GDH and several other PQQ-dependent enzymes has remained
controversial because of the absence of comprehensive structural
data. We have determined the crystal structure of a ternary
complex of s-GDH with PQQ and methylhydrazine, a competitive
inhibitor of the enzyme. This complex, refined at 1.5-Å resolution
to an R factor of 16.7%, affords a detailed view of a cofactor-
binding site of s-GDH. Moreover, it presents the first direct obser-
vation of covalent PQQ adduct in the active-site of a PQQ-depen-
dent enzyme, thereby confirming previous evidence that the C5
carbonyl group of the cofactor is the most reactive moiety of PQQ.
Quinoproteins form a class of dehydrogenases distinct fromthe NAD(P)1- and flavin-dependent enzymes (1). They use
one of four different quinone cofactors for the oxidation of a
wide variety of compounds (2–5). The prototypical cofactor
pyrroloquinoline quinone (PQQ; Fig. 1) is present in the bac-
terial quinoproteins methanol dehydrogenase (MDH) and glu-
cose dehydrogenase (GDH) (2, 6, 7). On the basis of a variety
of biochemical and kinetic data for MDH and the soluble GDH
(s-GDH), two reaction mechanisms have been proposed for
PQQ-containing enzymes (Fig. 2). The first mechanism includes
general base-catalyzed proton abstraction from the oxidizable
hydroxyl group, followed by the formation of a covalent sub-
strate–PQQ complex and product elimination (Fig. 2 A) (8–11).
The second possible reaction mechanism involves general base-
catalyzed proton abstraction in concert with hydride transfer to
PQQ and subsequent tautomerization to pyrroloquinoline qui-
none (PQQH2) (Fig. 2B) (10–12). The substrate or hydride
anion is normally considered to form an adduct at the PQQ C5
position (8–11, 13, 14), but Zheng and Bruice (12) have calcu-
lated that a mechanism involving hydride transfer from the
substrate to the PQQ C4 atom may be energetically favorable.
Thus, structural information is required to undisputedly resolve
which of the two carbonyl groups of the ortho-quinone group of
PQQ is most reactive in an enzymatic environment.
s-GDH has long been thought to be exclusively present in the
periplasmic space of the bacterium Acinetobacter calcoaceticus,
but recently homologous sequences have been identified in the
genomes of four other bacteria (15). s-GDH is a basic (pI 5 9.5)
dimeric enzyme of identical subunits of 50 kDa each (454
residues after cleavage of a 24-residue signal peptide) (16, 17).
The enzyme requires calcium for dimerization as well as for
binding of PQQ (18). It oxidizes a broad range of aldose sugars
to the corresponding lactones, with concomitant reduction of
PQQ to PQQH2 (Fig. 2) (19). Several artificial electron accep-
tors are able to reoxidize the cofactor (16). Stopped-flow
kinetics indicated that the oxidation of glucose has a pH
optimum of around 7 (11).
Recently, we reported the three-dimensional structure of the
dimeric apo-form of s-GDH at 1.7 Å (15). The monomers fold
into a b-propeller structure consisting of six four-stranded
b-sheets. Three calcium ions per monomer are present in the
crystal structure, of which two are located close to the dimer-
ization interface, whereas the third calcium ion was predicted to
be ligated by PQQ in the active site of the enzyme. Here, we
present the three-dimensional structure of s-GDH in complex
with PQQ and methylhydrazine (MH), a competitive inhibitor of
the protein (hydrazine inhibits the conversion of glucose with a
Ki value of 5 6 0.5 mM; A. Dewanti and J. A. Duine, personal
communication). This structure presents the first detailed view
of PQQ binding in s-GDH, shows how MH inhibits the enzyme,
and identifies the reactive moiety of the functional ortho-
quinone group of PQQ.
Methods
Crystallization and Complex Formation. Colorless crystals of the
apo-form of s-GDH were prepared as described previously (15).
They belong to space group P21, and the cell dimensions are a 5
61.9 Å, b 5 94.2 Å, c 5 86.5 Å, b 5 104.9° at room temperature.
A double-soaking procedure was applied in an attempt to obtain
crystals of holo-s-GDH in complex with MH. Crystals were first
soaked for at least 8 hr in a stabilizing solution containing 1 mM
PQQ, 3 mM CaCl2, 120 mM NaCl, and 25% (wtyvol) polyeth-
ylene glycol (PEG) 6000 in 50 mM 2-[N-cyclohexylamino]-
ethanesulfonic acid (CHES) buffer, pH 9.2, yielding blue crystals
of the holoenzyme belonging to space group P21 with similar cell
dimensions as described for crystals of the apoenzyme. Subse-
quently, such a blue crystal was soaked in a solution containing
1 mM MH, 3 mM CaCl2, 120 mM NaCl, and 25% (wtyvol)
PEG6000 in 50 mM 2-[N-cyclohexyamino]-ethanesulfonic acid
(CHES) buffer, pH 9.2. In the course of the 2.5-hr soaking time,
the color of the crystal changed from blue to light green. At this
point, the crystal was flash frozen in a cryo-protecting solution
consisting of 3 mM CaCl2, 120 mM NaCl, 25% (wtyvol)
PEG6000, and 15% (volyvol) glycerol in 50 mM CHES buffer,
pH 9.2.
Data Collection, Processing, and Structure Refinement. A complete
data set was collected to 1.5-Å resolution at beam line ID14–3
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at the European Synchrotron Radiation Facility, Grenoble. Data
processing and reduction were performed with DENZOy
SCALEPACK (20). The data set was divided into a work and a test
set (21), consisting of 5% of the reflections and including all
reflections of the apoenzyme refinement test set. Refinement
was initially done with REFMACyARP and auxiliary programs
from the CCP4 suite (22). The apo-structure, refined at 1.7-Å
resolution, was used as an initial model. After a few rounds of
model refinement, some manual adjustments were made, and
the loop regions of residues A335-A344, B105-B110, and B335-
B344, not present in the apo-model because of the absence of
convincing electron density, were added to the model by using
the program O (23). At this stage, sA-weighted (24) 2Fo 2 Fc and
Fo 2 Fc electron-density maps unequivocally revealed the pres-
ence of PQQ in the crystals. PQQ was manually fitted to the
electron density in both monomers and initially refined with
planarity restraints on the entire molecule. After initial refine-
ment, sA-weighted (24) 2Fo 2 Fc and Fo 2 Fc electron density
maps showed that the cofactor is not completely planar in either
molecule (Fig. 3 A and B). In the next round of refinement, tight
planarity restraints were maintained on each of the three rings
of PQQ and the carboxylate groups, but restraints constraining
planarity between rings andyor carboxylates were released. The
resulting PQQ model clearly fitted the electron density much
better (Fig. 3 C and D).
At this point, continuous density from PQQ to a water
molecule could be recognized in monomer B in the 2Fo 2 Fc
electron density map. A MH molecule, covalently attached to the
C5 atom of PQQ with an occupancy of 0.7, fitted this density well
(Fig. 3C). Attempts to refine monomer A in an identical fashion
did not result in the appearance of continuous electron density.
Instead, a MH molecule could be fitted to a large piece of density
at a different position in the active site of that monomer (Fig.
3D). Nevertheless, utilization of the bulk solvent correction and
anisotropic scaling procedures of X-PLOR (25) resulted in the
appearance of positive Fo 2 Fc electron density near the
unligated PQQ C5 atom in monomer A, suggesting that MH may
have partially formed a covalent complex with PQQ in this
monomer. Refinement of the occupancies of the two conforma-
tions showed that this covalent complex has an occupancy of only
0.26 (occupancy is 0.74 for the noncovalently bound MH con-
formation). A summary of data collection and structure refine-
ment statistics is given in Table 1.
Results and Discussion
Structure Refinement. The s-GDH-PQQ-MH complex was refined
to a crystallographic R factor of 17.4% (with a free R factor of
19.5%). The final model has excellent stereochemistry (Table 1).
It comprises two protein monomers, six calcium ions, 900 water
molecules, one glycerol, one PQQ, one MH molecule with two
conformations, and two carbinolamine type PQQ-MH com-
plexes. Some of these ligand moleculesycomplexes have partial
occupancies. The model contains all protein residues with the
exception of residues A105-A110, A451–454, and B453–454.
PQQ Binding. PQQ resides in a deep and broad solvent-accessible
cleft in the center of each monomer, near the top of the
b-propeller structure (Fig. 4). The binding of the cofactor to
s-GDH is predominantly governed by polar interactions (Fig. 5).
The C2, C7, and C9 carboxyl groups of PQQ (PQQ nomencla-
ture explained in Fig. 1) form salt bridges with Arg-408, Lys-377,
and Arg-406, respectively. The ortho-quinone O4 and O5 atoms
are bound by Asn-229 and Arg-228, respectively. The N6, O7A,
and O5 atoms of PQQ are ligands for the active-site calcium ion.
The other calcium ligands are provided by the two main chain
carbonyl oxygen atoms of Gly-247 and Pro-248 and two water
molecules.
The overall binding of PQQ is similar to that in the active site
of MDH (26, 27). In both proteins, equatorial interactions are
polar, whereas hydrophobic stacking interactions are formed on
Fig. 1. Structure of PQQ. Atom nomenclature is indicated.
Fig. 2. Possible reaction mechanisms for s-GDH. (A) The addition-elimination mechanism. (B) Mechanism comprising direct hydride transfer and tautomer-
ization to PQQH2 (upper right structure).
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both sides of the plane of PQQ. The active-site calcium ion and
one arginine side chain are ligated to PQQ in an almost identical
fashion.
Conformation of PQQ. Because the ternary complex is refined at
1.5-Å resolution, it presents a detailed view of the conformation
of PQQ in s-GDH (Fig. 6A). A superposition of the two PQQ
molecules in the dimer shows that the cofactor binds in an
identical fashion in the two active sites (not shown). The
conformation of PQQ, mostly unligated in monomer A and
complexed with MH in monomer B, is virtually the same in either
active site. Only the conformation of the C5 atom varies because
of a different hybridization state (sp2 in PQQ vs. sp3 in the
covalent adduct; see below). The geometry of the cofactor
molecule deviates significantly from planarity in both active sites.
The three carboxylate groups are all to some extent twisted of
the plane of the monocyclic ring to which they are attached. The
orientations of these groups seem optimized for polar interac-
tions with the protein ligands (Fig. 5). The O4 and O5 atoms of
the ortho-quinone are also of the plane of the cofactor. The
possibility that these oxygen atoms may be positioned of the
molecular plane was previously suggested by model studies of
Zheng and Bruice (12), who proposed that they may be posi-
tioned on opposite sides of the PQQ plane to alleviate repulsive
interactions. In the present structure, however, both atoms are
positioned on the same side of the plane. This is compensated for
by several favorable interactions (Fig. 5). The O4 atom forms a
hydrogen bond with the ND2 atom of Asn-229, whereas the O5
atom is within hydrogen bonding distance of the NH1 atom of
Arg-228 and the active-site calcium ion. The deformations
around the C6A-C9A and C9-C9X bonds orient the carboxylic
groups at C9 and C7 optimally for polar interactions with
Arg-406 and Lys-377, respectively (Fig. 5). Thus, the nonplanar
conformation of the cofactor seems to be stabilized by polar
Fig. 3. (A) 2Fo-Fc electron density, contoured at 1.5 s, for PQQ, refined as a
completely planar molecule. (B) Density (3 s Fo-Fc) (light grey) and 23 s Fo-Fc
density (dark grey) for planar PQQ. (C) Electron density (2Fo-Fc), contoured at
1 s, for the final model of the carbinolamine type complex in monomer B. (D)
Electron density (2Fo-Fc), contoured at 1 s, for the final model of PQQ and
noncovalently bound MH in monomer A. This picture was created with
BOBSCRIPT (30).
Fig. 4. Ribbon diagram of one s-GDH monomer. PQQ and MH are shown in
ball-and-stick representation. The calcium ion is shown as a large grey sphere.
Oxygen, nitrogen, and carbon atoms are shown in white, grey, and black,
respectively. This picture was produced with MOLSCRIPT (31).
Table 1. Statistics of data collection and refinement and quality
of the final model
Space group P21
Cell dimensions:
a, Å, b, Å, c, Å, b, ° 60.6, 92.7, 85.7, 105.4
Resolution range, Å 100–1.50
Total number of reflections 580,379
No. of unique reflections 142,076
Rmerge(I)* 0.033
Rmerge(I)* (1.53–1.50 Å) 0.340
Completeness of data, % 97.8
Completeness, % (1.53–1.50 Å) 91.2
Refinement resolution range, Å 20–1.50
No. of nonhydrogen atoms in protein model 7,040
No. of calcium atoms 6
No. of ligand nonhydrogen atoms 90
No. of water molecules 900
Final R factor†yR free‡ 0.174y0.195
Root mean square deviations from
ideality for
Bond lengths, Å 0.027
C bond angles, ° 2.9
Dihedral angles, ° 27.2
Improper dihedral angles, ° 1.6
*Rmerge (I) 5 (hkl(I u Ii(hkl) 2 ^I(hkl)&uy(hkl(iyi(hkl)
†R factor 5 (hkluuFobs, worku 2 kuFcalcuuy(hkluFobs, worku
‡R free 5 (hkluuFobs, testu 2 kuFcalcuuy(hkluFobs, testu








interactions with several protein side chains and the active-site
calcium ion of s-GDH.
Noncovalently Bound MH. In the majority (74%) of the monomers
A in the crystal, MH is bound in a noncovalent fashion, packed
against one side of a wide cavity that is present in the surface of
the protein directly above PQQ. In this active site, MH is bound
in two slightly different conformations, which differ only by a
rotation of the methyl group around the N1–N2 bond. This
methyl group makes hydrophobic interactions with Tyr-343 and
Trp-346, the N2 atom has no interactions with the protein
surroundings, and the N1 atom has a water-mediated interaction
with the active-site calcium ion. Interestingly, a glycerol solvent
molecule is present at a similar position in the crevice above
PQQ in the holoenzyme structure (unpublished results). Be-
cause this crevice is wide enough to accommodate even larger
compounds such as glucose, it may well be the substrate-binding
site of s-GDH.
Covalent Carbinolamine Type Complex of PQQ and MH. In 26% and
70% of the monomers A and B in the crystal, respectively, MH
is covalently bound to the C5 atom of PQQ. Compared with
noncovalently bound MH, the inhibitor N1 atom has moved over
a distance of 2.6 Å in the direction of the PQQ C5 atom. This
latter atom has been pushed up above the plane of PQQ and has
adopted a tetrahedral configuration (Fig. 6B).
The carbinolamine type PQQ–MH complex (Fig. 7) is the first
structure of a covalent adduct of any compound to PQQ in an
enzymatic setting. Small molecule structures of PQQ adducts of
methanol, acetone, and cyclopropanol have been determined
previously (2, 9, 28). Furthermore, spectroscopic evidence indi-
cates that a variety of compounds are able to form adducts at the
PQQ C5 position in solution (29). These results show that the
reactivity of PQQ toward nucleophiles is highest at the C5 atom,
in solution as well as in the active site of s-GDH. Therefore, it
Fig. 5. Hydrogen bonding interactions in the active site of s-GDH. Distances
are given in Ångstroms. Oxygen, nitrogen and carbon atoms are shown in
white, grey and black, respectively. This picture was created with MOLSCRIPT
(31).
Fig. 6. (A) Conformation of unligated PQQ in monomer A. (B) Conformation of the C5 atom of the carbinolamine type complex in monomer B. Angles are given
in degrees. Oxygen, nitrogen, and carbon atoms are shown in white, grey, and black, respectively. This picture was created with MOLSCRIPT (31).
Fig. 7. Structure of the adduct of PQQ and MH. Atom nomenclature is
indicated for the MH atoms and for the carbon atoms of the ortho-quinone
group of PQQ.
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seems likely that the reaction mechanism of s-GDH, and possibly
other PQQ-dependent proteins, proceeds through nucleophilic
attack of a substrate or hydride anion on the PQQ C5 atom and
not on the C4 atom, as has been proposed on the basis of ab initio
calculations (12).
Two Different Modes of Binding. MH is bound in two distinct modes
in the two active sites of the homodimer. The covalent PQQ–MH
complex has been formed in about 26% and 70% of the A and
B monomers in the crystal, respectively, whereas noncovalently
bound MH is present in the active site of the remaining 74% of
the A subunits. This indicates that the reactivity of the two active
sites in the dimer is not identical. However, no significant
structural differences are present between the two active sites
nor in the area between the two cofactors, including the dimer-
ization interface. The most pronounced difference between the
active sites is the flexibility of the loops comprising residues
335–344. The B factors of the Ca-atoms of monomer A in this
loop are on average 10 Å2 lower than they are in monomer B. The
more rigid loop of monomer A makes hydrophobic interactions
with the noncovalently bound MH, whereas the more flexible
loop of subunit B does not. It thus seems that the binding of MH
in a noncovalent form is related to a relatively rigid conforma-
tion of the 335–344 loop. Because the loops of the two monomers
make different interactions with crystallographically related
molecules, the differential reactivity of these monomers toward
MH may be a result of differing crystal packing interactions.
Inhibition Mechanism. The two different binding modes of MH in
the dimer suggest a mechanism for the inhibition of s-GDH by
MH. First, the inhibitor may enter the wide solvent accessible
crevice in the protein surface and might pack against the face
constituted by residues 343 and 346, making a water-mediated
interaction with the active-site calcium, as is observed in mono-
mer A. In the next step, MH could move over a distance of
approximately 2.6 Å in the direction of the PQQ C5 atom. The
lone pair of the N1 atom of MH could then perform a nucleo-
philic attack on the C5 atom of PQQ. The reactivity of this C5
atom toward nucleophilic compounds may be enhanced by
polarization of the C5–O5 bond (11, 12). Polarization of this
bond may be accomplished by the nearby Arg-228 and the
active-site calcium ion. Formation of the carbinolamine type
PQQ–MH complex could be completed by the net transfer of the
proton from the N1 atom of MH to the O5 atom of PQQ. A
similar function of increasing the activity of the PQQ C5 atom
has been proposed for the presence of positive charge close to
the O5 atom in the active site of MDH (27).
This proposed inhibition mechanism is similar to the addition-
elimination mechanism (Fig. 2), which is one of the two reaction
mechanisms that have been proposed for the oxidation of
glucose on the basis of kinetic experiments with s-GDH (11). It
is tempting to assume that this PQQ–MH complex provides the
lacking structural evidence to substantiate the addition-
elimination mechanism. However, glucose and MH are chemi-
cally distinct with respect to their oxidizable groups. MH is a
much more reactive compound than glucose, because the N1
atom of MH can directly perform a nucleophilic attack with its
lone pair, whereas the O1 atom of glucose first has to lose a
proton before it can act as a nucleophile. The prerequisite of
releasing the proton from the glucose O1 atom before reaction
with PQQ may demand a completely different orientation of
glucose, which might be unsuitable for the actual addition to
occur, and it thus remains to be established whether s-GDH
oxidizes its substrates via covalent addition.
Conclusions
Our results suggest that the native state of PQQ in s-GDH is
nonplanar and that the substrate binding site is located directly
above the cofactor. Moreover, MH is likely to inhibit s-GDH via
covalent addition of its N1 atom to the cofactor C5 atom, which
adopts a tetrahedral conformation in the resulting carbinolamine
type PQQ–MH complex. This structure represents the first
covalent adduct in a PQQ-dependent protein and provides
conclusive structural evidence that the carbonyl group at the
cofactor C5 position is the most reactive group of PQQ in the
active site of s-GDH.
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